Class summary at a glance.

Every drug in the Fluoroquinolone Antibacterial class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 6tracked in Part D
CY24 Part D spend: $113.2Mcombined across class
Total Rx claims: 12.6M9.4M unique beneficiaries
Generic mfrs (active): 61across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Ciprofloxacin

Brand: CILOXAN · 7.2M Part D claims (CY24) · 5.4M beneficiaries · First FDA approval: 1987-10-22

20 generic mfrs 33 plans require PA

Low NADAC$0.089

→

Avg plan cost$2.16

Part D spend $47.8M 24× spread, current vs floor

Class share

42%

of class CY24 spend

View profile →

Moxifloxacin

Brand: Moxifloxacin · 1.7M Part D claims (CY24) · 1.1M beneficiaries · First FDA approval: 2003-05-07

20 generic mfrs 34 plans require PA Discontinued

Low NADAC$1.73

→

Avg plan cost$3.33

Part D spend $41.8M 2× spread, current vs floor

Class share

37%

of class CY24 spend

View profile →

Levofloxacin

3.8M Part D claims (CY24) · 2.9M beneficiaries · First FDA approval: 2010-11-10

21 generic mfrs 54 plans require PA

Low NADAC$0.109

→

Avg plan cost$0.449

Part D spend $23.6M 4× spread, current vs floor

Class share

21%

of class CY24 spend

View profile →

Ciprofloxacin Otic Solution,

— Part D claims (CY24) · First FDA approval: 2024-11-15

Brand-only (no generics)

Low NADAC$6.93

→

Avg plan cost$6.93

Part D spend — 1× spread, current vs floor

Class share

of class CY24 spend

View profile →

Levofloxacin In

Brand: Levofloxacin · — Part D claims (CY24) · First FDA approval: 2016-02-10

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Llevofloxacin

Brand: Levofloxacin · — Part D claims (CY24) · First FDA approval: 2024-05-22

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.